All Research News articles – Page 36
-
NewsWhy killer cells can lapse into ‘exhausted’ CD8+ T cells that no longer can stem disease
In a detailed study of exhausted T cell subsets researchers show that a transcriptional repressor called Gfi1 is a key regulator of the subset formation of exhausted CD8+ T cells and may offer a key to reducing exhaustion.
-
NewsNew study: Powerboats can impact lakes below the surface, stimulating algaL growth
Large surface waves produced by powerboats are a mainstay for recreational watersports. A new study shows that beneath the surface, factors such as propeller thrust and other types of waves can impact delicate lakebed ecosystems.
-
NewsOrganized scientific fraud is growing at an alarming rate, study reveals
Although concerns around scientific misconduct typically focus on lone individuals, a study of scientific fraud has uncovered sophisticated global networks of individuals and entities, which systematically work together to undermine the integrity of academic publishing.
-
NewsNew mega RNA virus may hold the key to mass oyster die-offs
Scientists have discovered a previously unknown virus in farmed Pacific oysters during a mass die-off in B.C., Canada. The discovery serves as a reminder that growers should exercise caution when moving young oysters, to prevent potential spread of pathogens.
-
NewsResearchers discover cause of sea star wasting disease
Researchers have revealed the cause of sea star wasting disease (SSWD). The marine epidemic has killed billions of sea stars—representing more than 20 different species from Alaska to Mexico. SSWD is considered the largest marine epidemic ever documented in the wild.
-
NewsBrewed chicken protein made by precision fermentation tested in pet food
In a groundbreaking new project, scientists used precision fermentation to produce brewed chicken protein and evaluated it for use in pet food. Dogs that consumed the protein in their kibble during a six-month study had beneficial digestive effects, they found.
-
NewsScientists discover how leukemia virus stays hidden in the body
A research team has discovered how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their findings identify a previously unknown genetic “silencer” element that keeps the virus in a dormant, undetectable state.
-
NewsStatistical modeling can help tackle neglected tropical diseases among migrant populations
A study of migrants in Italy has shown how statistical modelling can help improve the identification of Neglected Tropical Disease (NTD) infections.
-
NewsQ&A: Why do symptoms linger in some people after an infection?
A new review highlights that long COVID and ME/CFS share many of the same biological problems such as inflammation in the brain, issues with how cells produce energy, and problems with the immune system.
-
NewsHelping me, inhibiting you: Analysis of interactions between intestinal microbiota
Researchers have analyzed the interactions between two bacteria that make up intestinal microbiota. While Faecalibacterium prausnitzii inhibits the growth of Fusobacterium varium, F. varium promotes the growth of F. prausnitzii.
-
NewsSkin test reagent proves effective and safe for TB diagnosis in children
A new class of skin test reagents based on Mycobacterium tuberculosis (MTB)-specific antigens has been developed. A phase III clinical trial suggests that C-TST is an effective and safe option for diagnosing pediatric TBI.
-
NewsScientists pinpoint optimal dose of methylprednisolone for treating severe Mycoplasma pneumoniae pneumonia
Investigators have compared the efficacy of low- versus high-dose of methylprednisolone in preventing pulmonary lesions in children with severe Mycoplasma pneumoniae pneumonia.
-
NewsImmunoglobulin replacement therapy shows no reduction in serious infections for patients with CLL
In patients with chronic lymphocytic leukemia (CLL), regular treatment with immunoglobulin replacement therapy was not associated with a reduced risk of serious infections requiring hospitalization, according to a study published in Blood Advances.
-
NewsLarge study uncovers specific impacts of flooding on older adult health
New research examining 17 years of data from Medicare hospitalization claims and major flooding events finds increased rates of skin diseases, nervous system diseases, and injuries or poisonings among adults aged 65 and older following major floods.
-
NewsGene therapy may block HIV transmission during breastfeeding, study shows
Delivering broadly neutralizing antibodies against HIV-1 to newborns via gene therapy provided them with multi-year protection from HIV/AIDS infection, according to an animal study.
-
NewsStudy highlights the severity of acute necrotizing encephalopathy in kids with the flu
For a small subset of children, influenza can trigger a rare but serious complication called influenza-associated acute necrotizing encephalopathy (ANE). Now, findings of a multicenter study suggest that ANE is often fatal in these children — despite intensive treatment.
-
NewsMicrobiome breakthrough: Gut bacterium may hold key to future treatments for widespread chronic diseases
Scientists have identified a common specific gut bacterial strain that may open the door to a new class of therapeutics. This bacterium produces two proteins that influence the body’s hormonal balance and affect weight, bone density, and blood sugar levels.
-
NewsGut microbiome transplants show promise for boosting cancer immunotherapy
A comprehensive new review examines the effects of transferring healthy gut bacteria to cancer patients receiving immune checkpoint inhibitors (ICIs).
-
NewsEvaluating the effect of liquid-handling speed on yeast growth using robots
A new experiment indicated that the fastest pipetting speed on cells can be set without relying on thumb rules or guesswork, which is an important guideline for increasing the efficiency and reproducibility of robot-based experiments.
-
NewsClinical trial finds safe, effective treatment for children with severe post-Covid syndrome
Researchers have discovered that a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID. A small, randomized clinical trialfound the oral drug larazotide was both safe and effective in treating children with MIS-C.